Pfizer Unusual Options Activity
Pfizer Unusual Options Activity
From the overall spotted trades, 9 are puts, for a total amount of $523,182 and 17, calls, for a total amount of $1,209,045.Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer.
擁有大量資金的鯨魚對輝瑞採取了明顯的看淡態度。
Looking at options history for Pfizer (NYSE:PFE) we detected 26 trades.
查看輝瑞（紐交所:PFE）的期權歷史，我們發現了26筆交易。
If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 50% with bearish.
如果考慮每筆交易的具體情況，準確地說有46%的投資者看好開倉交易，50%看淡。
From the overall spotted trades, 9 are puts, for a total amount of $523,182 and 17, calls, for a total amount of $1,209,045.
從所有交易中，有9筆看跌交易，總額爲523,182美元，17筆看漲交易，總額爲1,209,045美元。
Expected Price Movements
預期價格波動
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $18.0 and $35.0 for Pfizer, spanning the last three months.
通過評估交易量和未平倉合約量，很明顯主要的市場操盤客正集中在輝瑞的價格區間在18.0美元和35.0美元之間，涵蓋過去三個月。
Volume & Open Interest Trends
成交量和未平倉量趨勢
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Pfizer's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Pfizer's significant trades, within a strike price range of $18.0 to $35.0, over the past month.
檢視成交量和未平倉合約提供了對股票研究的重要見解。這些信息在評估輝瑞特定執行價的期權流動性和興趣水平中至關重要。以下我們展示了過去一個月內，輝瑞重要交易所在的執行價區間從18.0美元至35.0美元，看跌和看漲的成交量和未平倉合約的趨勢概覽。
Pfizer Option Activity Analysis: Last 30 Days
輝瑞期權活動分析：最近30天
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE | CALL | SWEEP | BEARISH | 01/16/26 | $1.32 | $1.24 | $1.24 | $35.00 | $344.5K | 27.6K | 3.2K |
| PFE | CALL | SWEEP | BULLISH | 12/18/26 | $2.2 | $2.15 | $2.2 | $35.00 | $224.7K | 1.0K | 1.8K |
| PFE | CALL | SWEEP | BULLISH | 03/21/25 | $0.85 | $0.75 | $0.85 | $32.50 | $127.6K | 16.3K | 1.5K |
| PFE | PUT | SWEEP | BULLISH | 12/19/25 | $6.8 | $6.7 | $6.7 | $35.00 | $123.2K | 8.7K | 300 |
| PFE | PUT | SWEEP | BULLISH | 11/21/25 | $6.75 | $6.65 | $6.65 | $35.00 | $79.1K | 457 | 51 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 輝瑞 | 看漲 | SWEEP | 看淡 | 01/16/26 | $1.32 | $1.24 | $1.24 | 35.00美元 | $344.5K | 27.6K | 3.2K |
| 輝瑞 | 看漲 | SWEEP | 看好 | 12/18/26 | $2.2 | $2.15 | $2.2 | 35.00美元 | 224.7千美元 | 1.0K | 1.8K |
| 輝瑞 | 看漲 | SWEEP | 看好 | 03/21/25 | $0.85 | 0.75美元 | $0.85 | $32.50 | $127.6K | 16.3K | 1.5K |
| 輝瑞 | 看跌 | SWEEP | 看好 | 2025年12月19日 | $6.8 | $6.7 | $6.7 | 35.00美元 | $123.2K | 8.7K | 300 |
| 輝瑞 | 看跌 | SWEEP | 看好 | 11/21/25 | 其股票的收盤價格昨天爲$5.75。 | $6.65 | $6.65 | 35.00美元 | $79.1千美元 | 457 | 51 |
About Pfizer
關於輝瑞
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
輝瑞是全球最大的製藥公司之一，年銷售額接近500億美元（不包括COVID-19產品銷售）。它歷史上銷售過許多種醫療保健產品和化學品，現在處方藥和疫苗佔據了銷售額的大部分。暢銷產品包括肺炎球菌疫苗Prevnar 13，癌症藥物Ibrance和心血管治療藥Eliquis。輝瑞在全球範圍內銷售這些產品，國際銷售佔總銷售額的近50%。其中，新興市場是主要貢獻者。
In light of the recent options history for Pfizer, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鑑於輝瑞最近的期權歷史，現在適合關注公司本身。我們旨在探索其當前的業績。
Where Is Pfizer Standing Right Now?
輝瑞現在處於何種狀態？
- Currently trading with a volume of 8,648,223, the PFE's price is up by 0.19%, now at $29.36.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 35 days.
- 輝瑞的成交量爲8,648,223，價格上漲0.19%，目前爲$29.36。
- RSI讀數表明該股目前可能接近超買水平。
- 預計業績發佈還有35天。
What Analysts Are Saying About Pfizer
分析師對輝瑞的評價
2 market experts have recently issued ratings for this stock, with a consensus target price of $45.0.
2位市場專家最近對這支股票發出評級，共識目標價爲$45.0。
Unusual Options Activity Detected: Smart Money on the Move
檢測到期權異動：智慧資金在行動。
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $45. * In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $45.
Benzinga Edge的期權異動板塊會在事件發生之前發現潛在的市場波動者。看看大資金在您喜愛的股票上做的什麼持倉。點擊這裏獲取。* Cantor Fitzgerald的一位分析師下調評級至增持，將價格目標調整爲$45。* 作爲謹慎舉措，Cantor Fitzgerald的一位分析師將評級下調至增持，設定目標價爲$45。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Pfizer with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高的利潤潛力。精明的交易者通過持續教育、戰略性的交易調整、利用各種因子並關注市場動態來減輕這些風險。通過Benzinga Pro實時警報跟上輝瑞的最新期權交易。
譯文內容由第三人軟體翻譯。